{'output': [['Synlogic Inc', 'COMP', 'Progresses', 'Clinical And Preclinical Pipeline', 'CONCEPT'], ['Synlogic Inc', 'COMP', 'Outlines', '2018 Catalysts', 'CONCEPT'], ['Synlogic Inc', 'COMP', 'Expects', 'Present Full Clinical Data', 'CONCEPT'], ['Synlogic Inc', 'COMP', 'Has', 'IND For Synthetic Biotic Medicine', 'PRODUCT'], ['Synlogic Inc', 'COMP', 'Has', 'IND For Synthetic Biotic Medicine', 'PRODUCT'], ['Synlogic Inc', 'COMP', 'Has', 'Treatment Of Hyperammonemia', 'CONCEPT'], ['Synlogic Inc', 'COMP', 'Has', 'Patients With Liver Disease', 'GPE'], ['Synlogic Inc', 'COMP', 'Expects', 'Additional Trials', 'CONCEPT'], ['Synlogic Inc', 'COMP', 'Expects', 'Trials In Patients With UCD', 'CONCEPT'], ['Synlogic Inc', 'COMP', 'Expects', 'Trials In Patients With PKU', 'CONCEPT'], ['FDA', 'ORG/REG', 'Cleared', 'IND For Synthetic Biotic Medicine', 'PRODUCT'], ['Synlogic Inc', 'COMP', 'Has', 'IND For Synthetic Biotic Medicine', 'PRODUCT'], ['Synlogic Inc', 'COMP', 'Has', 'Treatment Of Hyperammonemia In Patients With Liver Disease', 'CONCEPT']]}